CA 19-9 and the McGill Brisbane Symptom Score: predictors of pancreatic cancer survival
Background: Clinical tools that predict pancreatic adenocarcinoma (PAC) survival to help tailor treatments are lacking. Our surgical group has developed a clinical score, the McGill Brisbane Symptom Score (MBSS) that predicts PAC survival in resectable and non-resectable PAC. CA 19-9, a biomarker us...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
McGill University
2013
|
| Subjects: | |
| Online Access: | http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=116938 |